EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY 4.0

Comparison of the Efficacy of Transcatheter Arterial Chemoembolization Combined with Radiofrequency Ablation Versus Monotherapy in Patients with Liver Cancer

Shanfeng Li, Feng Zhao, Meng Sun, Haisong Wang, Jiangtao Bai, Long Zhou

Annali Italiani di Chirurgia · 2024

DOI: 10.62713/aic.3341 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Annali Italiani di Chirurgia, 2024. Verfasst von Shanfeng Li und 5 weiteren Autor:innen. Beteiligte Einrichtung: Interventional Vascular Surgery, Affiliated Hospital of Hebei University, 071000 Baoding, Hebei, China. Hauptthemen laut MEDLINE: Liver Neoplasms, Chemoembolization, Therapeutic, Carcinoma, Hepatocellular, Radiofrequency Ablation. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

AIM: This study assesses the effectiveness of combining transcatheter arterial chemoembolization (TACE) and radiofrequency ablation (RFA) in treating hepatocellular carcinoma (HCC). METHODS: Retrospective analysis of 125 HCC patients treated from 2020 to 2021, divided into two groups: monotherapy using TACE (n = 63), and a combined approach of RFA and TACE (n = 62). Comparison factors included clinical efficacy, liver function, tumor markers, complications, quality of life, and prognosis. RESULTS: The combined treatment group showed higher effectiveness (p < 0.05), improved liver function and tumor marker levels 4 weeks post-treatment (p < 0.05), significantly fewer complications (p < 0.05), and enhanced quality of life at the year-long follow-up (p < 0.05). The prognosis was better in the combination group, demonstrated by fewer recurrences and higher 1-year survival rates (p < 0.05). CONCLUSIONS: The dual approach of TACE and RFA shows improved results for HCC patients, including improved liver function, reduced tumor markers, fewer complications, and superior quality of life and prognosis. Consequently, combined treatment approach is endorsed for clinical practice.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Liver NeoplasmsChemoembolization, TherapeuticCarcinoma, HepatocellularRadiofrequency AblationQuality of LifeHumansRetrospective StudiesMaleFemaleCombined Modality TherapyMiddle AgedTreatment OutcomeAgedPrognosisCatheter AblationSurvival Rate

Autor:innen und Institutionen

  • Interventional Vascular Surgery, Affiliated Hospital of Hebei University, 071000 Baoding, Hebei, China.

Zitieren

APA

Li, S., Zhao, F., Sun, M., Wang, H., Bai, J., & Zhou, L. (2024). Comparison of the Efficacy of Transcatheter Arterial Chemoembolization Combined with Radiofrequency Ablation Versus Monotherapy in Patients with Liver Cancer. Annali Italiani di Chirurgia. https://doi.org/10.62713/aic.3341

Vancouver

Li S, Zhao F, Sun M, Wang H, Bai J, Zhou L. Comparison of the Efficacy of Transcatheter Arterial Chemoembolization Combined with Radiofrequency Ablation Versus Monotherapy in Patients with Liver Cancer. Annali Italiani di Chirurgia. 2024. doi:10.62713/aic.3341

BibTeX
@article{Li2024,
  author = {Li, Shanfeng and Zhao, Feng and Sun, Meng and Wang, Haisong and Bai, Jiangtao and Zhou, Long},
  title = {Comparison of the Efficacy of Transcatheter Arterial Chemoembolization Combined with Radiofrequency Ablation Versus Monotherapy in Patients with Liver Cancer},
  journal = {Annali Italiani di Chirurgia},
  year = {2024},
  doi = {10.62713/aic.3341}
}
Kostenlos starten →